Clinical trial
Radiation Therapy in Relapsed or Refractory Non-Hodgkin's Lymphoma Who Have…
NCT00031668 · NCIC Clinical Trials Group, Other · Completed
Key facts
| NCT number | NCT00031668 |
|---|---|
| Title | Radiation Therapy in Relapsed or Refractory Non-Hodgkin's Lymphoma Who Have Undergone Stem Cell Transplantation |
| Official title | A Phase III Study of Involved Field Radiation Therapy (IFRT) in Patients With Histologically Aggressive Non-Hodgkin's Lymphoma Following High Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation (ASCT) |
| Lead sponsor | NCIC Clinical Trials Group, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Radiation |
| Interventions | radiation therapy |
| Enrollment | 6 |
| Start date | Jan 31, 2001 |
| Primary completion | Feb 10, 2009 |
| Completion | Feb 10, 2009 |
| First posted | Jul 1, 2003 |
| Last update posted | Apr 1, 2020 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: